which is characterized by no response to chemotherapy or radiotherapy [16,17]. The advent of immune checkpoint inhibitor (ICI), including programmed cell death protein 1 (PD-1) and its ligand 1 (PD-L1), has brought a paradigm shift in melanoma therapy [18], but more than half of patient...
PD-L1/PD-1 pathway: a potential neuroimmune target for pain relief Daling Deng Tianhao Zhang Xiangdong Chen Cell & Bioscience(2024) Neurons upregulate PD-L1 via IFN/STAT1/IRF1 to alleviate damage by CD8+ T cells in cerebral malaria Yi Wang ...